DAVITA INC. Operating Lease Cost
DAVITA INC. (DVA) reported Operating Lease Cost of $702.18 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-02-11
- DAVITA INC. operating lease, cost for fiscal 2025 was $702.18M, a 1.89% increase from fiscal 2024.
- DAVITA INC. operating lease, cost for fiscal 2024 was $689.13M, a 0.53% decline from fiscal 2023.
- DAVITA INC. operating lease, cost for fiscal 2023 was $692.83M, a 1.92% increase from fiscal 2022.
- DAVITA INC. operating lease, cost for fiscal 2022 was $679.82M, a 0.88% increase from fiscal 2021.
| Period end | Operating Lease, Cost 12 month |
|---|---|
| 2025-12-31 | $702.18M 10-K · filed 2026-02-11 |
| 2024-12-31 | $689.13M 10-K · filed 2026-02-11 |
| 2023-12-31 | $692.83M 10-K · filed 2026-02-11 |
| 2022-12-31 | $679.82M 10-K · filed 2025-02-13 |
| 2021-12-31 | $673.90M 10-K · filed 2024-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |